Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$24.0 - $33.42 $25.5 Million - $35.5 Million
-1,061,435 Reduced 29.27%
2,564,349 $73.8 Million
Q2 2022

Aug 15, 2022

BUY
$24.78 - $33.36 $89.8 Million - $121 Million
3,625,784 New
3,625,784 $91.8 Million

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Sessa Capital Im, L.P. Portfolio

Follow Sessa Capital Im, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sessa Capital Im, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Sessa Capital Im, L.P. with notifications on news.